IDO1 and cancer: At the same time, the concomitant tryptophan metabolites by IDO1 such as kynurenine in cancer cells further induce T-lymphocytes to undergo apoptosis [97,98], as well as promote activation of immunosuppressive regulatory T-cells [98,99].